Flaggemelding
Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag kjøpt 240 000 aksjer i PCI Biotech Holding ASA. Etter handelen eier Hawkeye Invest AS 2 000 000 aksjer, noe som utgjør 5,36% av aksjene i PCI Biotech Holding ASA.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ritedose Opens Advanced Laboratory and Expands Analytical Capabilities to Accelerate Pharmaceutical Innovation—Positioning the Company as a Preferred Partner for Drug Development and Manufacturing
- Zenith Epigenetics Receives FDA Clearance for Registration Enabling Study of ZEN-3694 in NUT Carcinoma
- Microchip Introduces its First Turnkey Touch Controllers for Buttons, Sliders and Wheels with Parallel Sensing
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share